8-(4-(1-(Cyclopropylmethyl)piperidin-4-yl)-1H-pyrazol-1-yl)pyrido[3,4-d]pyrimidin-4(3H)-one

ID: ALA4532069

PubChem CID: 155546359

Max Phase: Preclinical

Molecular Formula: C19H22N6O

Molecular Weight: 350.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1[nH]cnc2c(-n3cc(C4CCN(CC5CC5)CC4)cn3)nccc12

Standard InChI:  InChI=1S/C19H22N6O/c26-19-16-3-6-20-18(17(16)21-12-22-19)25-11-15(9-23-25)14-4-7-24(8-5-14)10-13-1-2-13/h3,6,9,11-14H,1-2,4-5,7-8,10H2,(H,21,22,26)

Standard InChI Key:  XIMIJJARGYSDBU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 30  0  0  0  0  0  0  0  0999 V2000
   33.5736   -3.2068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5724   -4.0264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.2805   -4.4353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2787   -2.7980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9873   -3.2032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9881   -4.0222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6966   -4.4293    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.4049   -4.0185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4001   -3.1963    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.6910   -2.7930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2829   -5.2501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6229   -5.7320    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.8772   -6.5086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6945   -6.5067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9451   -5.7289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6867   -1.9758    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.1813   -7.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8485   -7.9141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3268   -8.5723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1401   -8.4891    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.4728   -7.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9923   -7.0775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6195   -9.1509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2861   -9.8970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6301  -10.3777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3762  -10.7111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
  3 11  1  0
 10 16  2  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 14 17  1  0
 20 23  1  0
 23 24  1  0
 25 24  1  0
 26 25  1  0
 24 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4532069

    ---

Associated Targets(Human)

KDM4B Tchem Lysine-specific demethylase 4B (165 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM4A Tchem Lysine-specific demethylase 4A (52245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM5B Tchem Lysine-specific demethylase 5B (814 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM5C Tchem Lysine-specific demethylase 5C (224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 350.43Molecular Weight (Monoisotopic): 350.1855AlogP: 2.09#Rotatable Bonds: 4
Polar Surface Area: 79.70Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.11CX Basic pKa: 9.29CX LogP: 1.12CX LogD: -0.52
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.78Np Likeness Score: -1.21

References

1. Le Bihan YV, Lanigan RM, Atrash B, McLaughlin MG, Velupillai S, Malcolm AG, England KS, Ruda GF, Mok NY, Tumber A, Tomlin K, Saville H, Shehu E, McAndrew C, Carmichael L, Bennett JM, Jeganathan F, Eve P, Donovan A, Hayes A, Wood F, Raynaud FI, Fedorov O, Brennan PE, Burke R, van Montfort RLM, Rossanese OW, Blagg J, Bavetsias V..  (2019)  C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.,  177  [PMID:31158747] [10.1016/j.ejmech.2019.05.041]

Source